🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Participants with Hodgkin's Disease (HD) who have been treated with cyto-re...
Status
Completed
Location
Washington University School of Medicine,Division of Bone Marrow Transplantation & Leukemia
Start Date
2004-11
Trial ID
NCT00396201
Treatments Being Tested
This is a single-group treatment, phase IV, open label study to assess the ...
Status
Completed
Location
Investigational Sites
Start Date
2021-10-22
Trial ID
NCT05087212
Treatments Being Tested
The goal of this clinical research study is to learn if treating stem cell ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-10
Trial ID
NCT01818284
Treatments Being Tested
The purpose of this study is to determine whether the combination of AMD310...
Status
Completed
Location
City of Hope Samaritan Bone Marrow Transplant Program
Start Date
2005-01
Trial ID
NCT00103610
This is a multi-site study with plerixafor in pediatric cancer patients. Th...
Status
Completed
Location
Investigational Site Number 51
Start Date
2014-03-03
Trial ID
NCT01288573
Treatments Being Tested
This is a phase II multi-institutional therapeutic study of NK-cell based n...
Status
Completed
Location
Emory University
Start Date
2011-09
Trial ID
NCT01370213
RATIONALE: Giving chemotherapy drugs, such as melphalan, before an autologo...
Status
Completed
Location
Kantonsspital Aarau
Start Date
2006-10
Trial ID
NCT00392691
This study will determine whether an intervention aimed at reducing sedenta...
Status
Completed
Location
QEII Health Sciences Centre
Start Date
2022-04-07
Trial ID
NCT03682523
Treatments Being Tested
Nursing interventions, which has been configured to conform In this study, ...
Status
Completed
Location
Sakarya Universty
Start Date
2019-10-23
Trial ID
NCT06781671
Treatments Being Tested
With a standard mobilization regimen using G-CSF, approximately 5% of allog...
Status
Completed
Location
Cellex Gesellschaft für Zellgewinnung mbH Köln
Start Date
2013-12
Trial ID
NCT01954914
Treatments Being Tested